DRUG UTILIZATION PATTERNS AND COSTS FOR ERYTHROPOIESIS-STIMULATING AGENTS IN ADULT PATIENTS WITH CHRONIC KIDNEY DISEASE

被引：0
|
作者：
Laliberte, Francois [1 ]
Lafeuille, Marie-Helene [1 ]
Bailey, Robert A. [2 ]
Senbetta, Mekre [2 ]
McKenzie, R. Scott [2 ]
Dea, Katherine [1 ]
Lefebvre, Patrick [1 ]
机构：
[1] Grp Anal, Montreal, PQ, Canada
[2] Centocor Ortho Biotech Serv LLC, Bridgewater, NJ USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2010年 / 55卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
38
引用
收藏
页码：A41 / A41
页数：1
相关论文
共 50 条
  • [21] Early response to erythropoiesis-stimulating agents in non-dialysis chronic kidney disease patients
    Michio Kuwahara
    Youhei Arai
    Eriko Takehara
    Yasunori Sasaki
    Tomoharu Yoshimine
    Keita Kusaka
    Satomi Shikuma
    Wataru Akita
    Shinichi Uchida
    Clinical and Experimental Nephrology, 2016, 20 : 585 - 594
  • [22] Responsiveness to Erythropoiesis-Stimulating Agents in Chronic Kidney Disease: Does Geography Matter?
    Luca De Nicola
    Francesco Locatelli
    Giuseppe Conte
    Roberto Minutolo
    Drugs, 2014, 74 : 159 - 168
  • [23] Early response to erythropoiesis-stimulating agents in non-dialysis chronic kidney disease patients
    Kuwahara, Michio
    Arai, Youhei
    Takehara, Eriko
    Sasaki, Yasunori
    Yoshimine, Tomoharu
    Kusaka, Keita
    Shikuma, Satomi
    Akita, Wataru
    Uchida, Shinichi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2016, 20 (04) : 585 - 594
  • [24] OPTA-therapy with iron and erythropoiesis-stimulating agents in chronic kidney disease
    Hoerl, W. H.
    Macdougall, I. C.
    Rossert, J.
    Schaefer, R. M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : III2 - III6
  • [25] Use of erythropoiesis-stimulating agents in children with chronic kidney disease: a systematic review
    Bruce, Gordon
    Schulga, Peter
    Reynolds, Ben C.
    CLINICAL KIDNEY JOURNAL, 2022, 15 (08) : 1483 - 1505
  • [26] Responsiveness to Erythropoiesis-Stimulating Agents in Chronic Kidney Disease: Does Geography Matter?
    De Nicola, Luca
    Locatelli, Francesco
    Conte, Giuseppe
    Minutolo, Roberto
    DRUGS, 2014, 74 (02) : 159 - 168
  • [27] Utilization Patterns of IV Iron and Erythropoiesis Stimulating Agents in Anemic Chronic Kidney Disease Patients: A Multihospital Study
    Joshi, Avani D.
    Holdford, David A.
    Brophy, Donald F.
    Harpe, Spencer E.
    Mays, Darcy
    Gehr, Todd W. B.
    ANEMIA, 2012, 2012
  • [28] An overview on safety issues related to erythropoiesis-stimulating agents for the treatment of anaemia in patients with chronic kidney disease
    Del Vecchio, Lucia
    Locatelli, Francesco
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (08) : 1021 - 1030
  • [29] The Safety of Erythropoiesis-Stimulating Agents for the Treatment of Anemia Resulting from Chronic Kidney Disease
    Roberto Robles, Nicolas
    CLINICAL DRUG INVESTIGATION, 2016, 36 (06) : 421 - 431
  • [30] Safety issues related to erythropoiesis-stimulating agents used to treat anemia in patients with chronic kidney disease
    Del Vecchio, Lucia
    Locatelli, Francesco
    EXPERT OPINION ON DRUG SAFETY, 2012, 11 (06) : 923 - 931
12345